Acute chest pain (ACP) is a common symptom that can signify a broad spectrum of conditions, ranging from benign to life-threatening. Differentiating between these possibilities is a complex task that requires a comprehensive and systematic approach.
The initial assessment of a patient presenting with ACP should include a detailed history, physical examination, and basic diagnostic tests. It is essential to identify risk factors for coronary artery disease (CAD), such as hypertension, diabetes, smoking, and family history. The nature, duration, and radiation of the pain can provide valuable clues to its etiology.
The differential diagnosis of ACP is vast. It includes cardiac causes like acute coronary syndrome (ACS) and pericarditis, gastrointestinal causes like gastroesophageal reflux disease (GERD) and peptic ulcer disease, respiratory causes like pulmonary embolism and pneumothorax, and musculoskeletal causes like costochondritis. Psychological causes, such as panic disorder, should also be considered.
Diagnostic testing for ACP should be guided by the suspected diagnosis. Electrocardiogram (ECG) and cardiac biomarkers are essential for diagnosing ACS. Chest X-ray can help identify pneumothorax and pneumonia. Computed tomography (CT) angiography can rule out pulmonary embolism. Endoscopy and esophageal pH monitoring can help diagnose GERD.
The management of ACP depends on the underlying cause. ACS requires immediate revascularization. GERD can be managed with proton pump inhibitors. Pulmonary embolism requires anticoagulation. Psychological causes may require cognitive-behavioral therapy and pharmacotherapy.
Acute chest pain is a challenging symptom that requires a comprehensive approach. Prompt identification and management of the underlying cause can significantly improve patient outcomes. Continuous professional development and staying abreast with the latest evidence can help healthcare professionals in this endeavor.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation